Target intelligence / Profile preview

Zinc finger and BTB domain-containing protein 17 (ZBTB17)

Target
ZBTB17
Molecular classification
Transcription factor, Zinc finger protein, BTB (POZ) domain family
01

Overview

Zinc finger and BTB domain-containing protein 17 (ZBTB17; also known as Miz-1) is a transcription factor comprising C2H2-type zinc fingers and a BTB/POZ domain. It acts as both a transcriptional activator and repressor depending on binding partners, including direct interaction with the oncogene Myc. ZBTB17 is essential for early lymphocyte (T- and B-cell) development by preventing apoptosis of precursors and is required for normal embryogenesis during gastrulation. It regulates key genes, such as cyclin D1 and RB1, influencing cell cycle progression and lineage fate. Aberrant function or expression of ZBTB17 is implicated in various cancers, developmental syndromes, and immune disorders.

Other names
Miz-1MIZ1Myc-interacting zinc finger protein 1ZNF151Zinc finger protein 151ZNF60Zinc finger protein 60pHZ-67
02

Mechanism of action

Modulation of gene transcription by direct DNA binding (activator or repressor); Protein-protein interaction—recruitment or inhibition of other transcription factors (e.g., Myc interaction)

03

Biological functions

Transcription regulation (activator or repressor depending on partners)Cell cycle controlApoptosis prevention (especially in lymphocyte development)Early embryonic development (gastrulation)Lymphocyte lineage commitment
04

Disease associations

Cancer (tumor suppressor and oncogenic roles in different contexts)Immunological diseases (lymphocyte development defects, hematopoietic malignancies)Dilated cardiomyopathyCongenital malformations (split-hand/foot malformation)
05

Safety considerations

Targeting broadly expressed transcription factors like ZBTB17 may risk off-target gene regulation and toxicity in essential cell populations.Disruption could impair immune development or provoke developmental defects
06

Biomarkers

ZBTB17 protein levels (potential biomarker in cancer, immunological disease; used in multiplex protein biomarker panels for research)

Beyond the preview

Go deeper on Zinc finger and BTB domain-containing protein 17 (ZBTB17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger and BTB domain-containing protein 17 (ZBTB17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call